LanguaTalk

Want to create an interactive transcript for this episode?

View more episodes

Podcast: OncLive® On Air

Episode: FDA Approval Insights: Ponatinib in Ph+ ALL

Description: Dr Jabbour expands on the multiple milestones achieved through ponatinib’s FDA approval for patients with Ph-positive ALL; the agent’s potency and unique mechanism of action; and key efficacy and safety data from the PhALLCON trial supporting this regulatory decision.

Click any word to see translations, usage examples & similar words. Then learn them using saved words.

Text not synced with the audio? See here for why certain podcasts won't sync.

Key for transcripts:

saved words | learned words

Colours will update after you refresh the page.